{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:49:43Z","timestamp":1791769783746,"version":"4.3.4"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1991,9]]},"abstract":"<jats:p>Chlorpromazine (CPZ), at a concentration of 60 micrograms\/ml of medium completely inhibited the replication of Escherichia coli. At concentrations below this MIC, CPZ caused transient induction of filamentation, such that by the end of 5 h, all of the cells were filaments, and by the end of 24 h, only rod-shaped E. coli were present. The reversion to normal morphology in the presence of CPZ was not due to either the degradation of CPZ or the selection of CPZ-resistant mutants. The electrophoretic pattern of proteins extracted from isolated cell envelopes of CPZ-induced filaments as well as from E. coli that reverted to normal morphology was distinctly different from that of the controls.<\/jats:p>","DOI":"10.1128\/aac.35.9.1923","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:05:50Z","timestamp":1340841950000},"page":"1923-1924","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["Effects of chlorpromazine on the cell envelope proteins of Escherichia coli"],"prefix":"10.1128","volume":"35","author":[{"given":"L","family":"Amaral","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratories, Bronx Lebanon Hospital Center, New York 10457."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lorian","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories, Bronx Lebanon Hospital Center, New York 10457."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.35.9.1923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.35.9.1923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:28:24Z","timestamp":1645457304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.35.9.1923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["10.1128\/AAC.35.9.1923"],"URL":"https:\/\/doi.org\/10.1128\/aac.35.9.1923","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]},"assertion":[{"value":"1991-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}